​

Eton Pharmaceuticals (ETON) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ETON Stock Forecast

Eton Pharmaceuticals (ETON) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $15.00 and a low of $15.00. This represents a 4.60% increase from the last price of $14.34.

- $3 $6 $9 $12 $15 High: $15 Avg: $15 Low: $15 Last Closed Price: $14.34

ETON Stock Rating

Eton Pharmaceuticals stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

ETON Price Target Upside V Benchmarks

TypeNameUpside
StockEton Pharmaceuticals4.60%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$11.33
Last Closing Price$14.34$14.34$14.34
Upside/Downside---20.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2512---3
Mar, 2512---3
Feb, 2512---3
Jan, 2512---3
Dec, 2411---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 28, 2024Chase KnickerbockerCraig-Hallum$15.00$8.4477.73%4.60%
Oct 04, 2024Swayampakula RamakanthH.C. Wainwright$11.00$6.9159.19%-23.29%
May 06, 2024Chase KnickerbockerCraig-Hallum$8.00$3.71115.63%-44.21%
Jul 25, 2022H.C. Wainwright$9.00$2.72230.88%-37.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025B. RileyBuyinitialise
Jan 08, 2025Craig-HallumBuyBuyhold
Oct 28, 2024Craig-HallumBuyBuyhold
Oct 04, 2024Craig-HallumBuyBuyhold
Oct 04, 2024Deutsche BankBuyBuyhold
Oct 04, 2024H.C. WainwrightBuyBuyhold
May 06, 2024Craig-HallumBuyinitialise

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.37$-0.12$-0.39$-0.04$-0.15----
Avg Forecast$-1.28$-0.08$-0.38$0.01$-0.13$0.53$1.28$1.72$2.40
High Forecast$-1.17$-0.07$-0.37$0.01$-0.10$0.86$2.01$2.63$3.18
Low Forecast$-1.38$-0.09$-0.39$0.01$-0.15$0.19$0.57$0.80$1.77
Surprise %7.03%50.00%2.63%-500.00%15.38%----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$39.00K$21.83M$21.25M$31.64M$39.01M----
Avg Forecast$1.16M$23.30M$21.80M$32.00M$37.91M$79.94M$131.46M$194.98M$232.81M
High Forecast$1.23M$24.73M$22.24M$40.06M$38.01M$97.55M$164.56M$244.08M$291.44M
Low Forecast$1.09M$21.87M$21.36M$25.58M$37.81M$62.31M$105.10M$155.89M$186.14M
Surprise %-96.64%-6.30%-2.52%-1.12%2.91%----

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-28.83M$-2.96M$-9.78M$-936.00K$-3.82M----
Avg Forecast$-32.70M$-2.05M$-9.75M$265.01K$-3.25M$14.09M$33.87M$44.96M$61.42M
High Forecast$-30.09M$-1.89M$-9.49M$340.41K$-2.55M$22.16M$51.55M$67.45M$81.53M
Low Forecast$-35.30M$-2.22M$-10.00M$189.62K$-3.94M$4.92M$14.62M$20.52M$45.41M
Surprise %-11.83%44.32%0.38%-453.19%17.69%----

ETON Forecast FAQ

Is Eton Pharmaceuticals stock a buy?

Eton Pharmaceuticals stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Eton Pharmaceuticals is a favorable investment for most analysts.

What is Eton Pharmaceuticals's price target?

Eton Pharmaceuticals's price target, set by 6 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $15 at the low end to $15 at the high end, suggesting a potential 4.60% change from the previous closing price of $14.34.

How does Eton Pharmaceuticals stock forecast compare to its benchmarks?

Eton Pharmaceuticals's stock forecast shows a 4.60% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Eton Pharmaceuticals over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Eton Pharmaceuticals’s EPS forecast?

Eton Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.53, marking a -453.33% decrease from the reported $-0.15 in 2024. Estimates for the following years are $1.28 in 2026, $1.72 in 2027, and $2.4 in 2028.

What is Eton Pharmaceuticals’s revenue forecast?

Eton Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $79.94M, reflecting a 104.90% increase from the reported $39.01M in 2024. The forecast for 2026 is $131.46M, followed by $194.98M for 2027, and $232.81M for 2028.

What is Eton Pharmaceuticals’s net income forecast?

Eton Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $14.09M, representing a -468.65% decrease from the reported $-3.823M in 2024. Projections indicate $33.87M in 2026, $44.96M in 2027, and $61.42M in 2028.